Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency
Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency
Recruiting · NCT06090669 · Registry updated 2026-10-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency | Bone Marrow Failure Disorders, Congenital Bone Marrow Failure Syndromes, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Infant, Newborn, Diseases, bone marrow disorder, hematologic disorder | Recruiting | Phase 1 | 2026-10-08 | NCT06090669 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | United States | 800 |